Registry for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to create a registry of people with type 1 diabetes living in Canada to understand the frequency and severity of low blood sugar (hypoglycemia) episodes. Participants will complete online questionnaires about their experiences with hypoglycemia, including symptoms, fears, and triggers such as insulin use, diet, and exercise. Anyone diagnosed with type 1 diabetes and residing in Canada can join. As an unphased trial, this study provides a unique opportunity to enhance the understanding of hypoglycemia in type 1 diabetes, potentially improving future care and management.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on collecting information about your experiences with hypoglycemia.
Why are researchers excited about this trial?
Researchers are excited about this trial because it uses an online questionnaire to gather real-world data from patients living with Type 1 Diabetes. Unlike traditional treatments that focus on medication or insulin therapy, this approach aims to understand the daily life experiences and challenges faced by individuals with the condition. By collecting insights directly from patients across different age groups, researchers hope to uncover patterns and factors that can lead to improved personalized care and better management strategies. This innovative method could pave the way for more tailored interventions and support systems, ultimately enhancing the quality of life for those living with Type 1 Diabetes.
Who Is on the Research Team?
Remi Rabasa-Lhoret
Principal Investigator
Institut de recherches cliniques de Montréal
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Phase 1
Participants complete a questionnaire to provide an overall picture of the population with type 1 diabetes in Canada.
Phase 2
Participants characterize the causes, experience, and consequences of hypoglycemia, and may provide additional medical data if they live in Quebec or Alberta.
Phase 3
Participants provide information on diabetes and hypoglycemia treatment, hyperglycemia management, and lifestyle factors.
Follow-up
Participants are monitored for hypoglycemic episodes and other health metrics over a 12-month period.
What Are the Treatments Tested in This Trial?
Interventions
- Online questionnaire - Phase 1
- Online questionnaire - Phase 2
- Online questionnaire - Phase 3
Find a Clinic Near You
Who Is Running the Clinical Trial?
Institut de Recherches Cliniques de Montreal
Lead Sponsor